USA – Mendel, a San Jose, CA-based clinical AI platform that understands the unstructured, natural language content within medical documents, raised $18m in Series A funding.
The round was led by DCM, with participation from OliveTree, Zola Global Investors and Millennium Technology Value Partners and return investors Launch Capital, SOSV, Bootstrap Labs and Chairman of UCSF Health Hub Mark Goldstein. In conjunction with the funding, Olive Tree Managing Partner, Nichola Eliovits, will join the board.The company intends to use the funds to grow its business and the team, across sales, business development, communications and human resources to expand headcount in its San Jose and Cairo, Egypt offices 4X by Q1
2022. Led by Dr. Karim Galil, Mendel CEO and founder, Mendel Health uses novel AI technology to absorb clinical data in medical literature as well as patient health records, to trigger a wide range of Real World Data applications.
The company also announced its partnership with eFax, an online faxing solution that is part of the Consensus Cloud Services Division of Internet information and services company J2 Global (Nasdaq: JCOM). 07/06/2021
2022. Led by Dr. Karim Galil, Mendel CEO and founder, Mendel Health uses novel AI technology to absorb clinical data in medical literature as well as patient health records, to trigger a wide range of Real World Data applications.
The company also announced its partnership with eFax, an online faxing solution that is part of the Consensus Cloud Services Division of Internet information and services company J2 Global (Nasdaq: JCOM). 07/06/2021
